CCC Intelligent Solutions Holdings Inc. Announces Third Quarter Fiscal 2021 Financial Results
CCC Intelligent Solutions Holdings reported financial results for Q3 2021, highlighting an 18% revenue growth to $176.6 million and a 31% increase in adjusted EBITDA to $70.1 million. The company saw a gross margin of 67%, down slightly from the previous year, while adjusted gross profit rose to $138.4 million with a margin of 78%. Notably, CCC refinanced its debt, lowering interest rates from 4.0% to 3.0%. For Q4 2021, revenue guidance is set between $182 million and $184 million, with expected year-over-year growth of 10% to 11%.
- 18% revenue growth to $176.6 million in Q3 2021.
- Adjusted EBITDA grew 31% to $70.1 million.
- Gross margin maintained at 67%; adjusted gross margin increased to 78%.
- Successfully refinanced debt, reducing effective interest rate from 4.0% to 3.0%.
- Multi-year renewals signed with a Top 5 insurer and one of the largest multi-store operators.
- GAAP net loss increased to $189.8 million from net income of $4.7 million in Q3 2020.
- GAAP operating loss was $189.2 million compared to operating income of $23.1 million in Q3 2020.
- Cash from operating activities decreased to $36.9 million from $43.0 million in Q3 2020.
- Free cash flow declined to $25.0 million from $31.7 million in Q3 2020.
“CCC continued to perform at a high level in the third quarter, highlighted by
Ramamurthy continued, “Our performance demonstrates the power of our growth model and we will continue to invest in the business to benefit our customers. We are thrilled with the pace of product innovation and the quality of customer feedback, giving us great confidence in our growth potential.”
Third Quarter 2021 Financial Highlights
Revenue
-
Total revenue was
for the third quarter of 2021, compared to$176.6 million for the third quarter of 2020. Adjusted for the impact of the divestiture of a portion of our professional services casualty solution in$157.8 million December 2020 , total revenue grew18% in the third quarter of 2021.
Profitability
-
GAAP gross profit was
, representing a gross margin of$118.8 million 67% , for the third quarter of 2021, compared with , representing a gross margin of$107.3 million 68% , for the third quarter of 2020. Adjusted gross profit was , representing an adjusted gross margin of$138.4 million 78% , for the third quarter of 2021, compared with , representing an adjusted gross margin of$113.4 million 76% , for the third quarter of 2020. -
GAAP operating loss was
for the third quarter of 2021, compared with GAAP operating income of$189.2 million for the third quarter of 2020. Adjusted operating income was$23.1 million for the third quarter of 2021, compared with adjusted operating income of$62.5 million for the third quarter of 2020.$49.1 million -
GAAP net loss was
for the third quarter of 2021, compared with GAAP net income of$189.8 million for the third quarter of 2020. Adjusted net income was$4.7 million for the third quarter of 2021, compared with$29.7 million for the third quarter of 2020.$21.1 million -
Adjusted EBITDA was
for the third quarter of 2021, compared with adjusted EBITDA of$70.1 million for the third quarter of 2020. Adjusted EBITDA grew$53.6 million 31% in the third quarter of 2021 as compared to the third quarter of 2020.
Liquidity
-
CCC had
in cash and cash equivalents and$160.5 million of total debt at$800.0 million September 30, 2021 . The Company generated in cash from operating activities and had free cash flow of$36.9 million during the third quarter of 2021, compared with$25.0 million generated in cash from operating activities and$43.0 million in free cash flow in the third quarter of 2020.$31.7 million
The information presented above includes non-GAAP financial measures such as “adjusted EBITDA,” “adjusted net income,” “adjusted operating income,” “adjusted gross profit,” “adjusted gross profit margin,” and “free cash flow.” Refer to “Non-GAAP Financial Measures” for a discussion of these measures and reconciliations of each non-GAAP financial measure to the most directly comparable GAAP financial measure.
3rd Quarter and Recent Business Highlights
- Announced the first touchless estimating experience in the industry. The AI-powered CCC® Estimate-STP uses advanced AI and insurer-driven rules to automatically initiate and populate detailed and actionable estimates in seconds. In market with four national insurers, CCC Estimate-STP offers touchless line level estimates from photos and is part of CCC’s broader offering that is digitizing the auto claims experience.
- Signed multi-year renewals with a Top 5 insurer and one of the country’s largest multi-store operators, or MSOs. As part of the multi-year agreements these customers have meaningfully expanded their annual commitment to CCC as they broadened the number of solutions they utilize from the platform.
-
Partnered with
Toyota to deliver Collision Assistance, a just-in-time support service, which is now available to drivers within theToyota and Lexus mobile apps. The CCC mobile technology combines guided accident documentation and access to claims and management services to assist drivers following a collision. This is an example of how CCC is delivering innovation that expands our ecosystem beyond traditional insurer and repair facility customers. -
Successfully completed the refinancing of its existing secured credit facility with a new credit agreement comprised of an
senior secured term loan facility (the “Term Loan”) and a$800 million senior secured revolving credit facility (the “Revolving Facility”) that lowered our effective interest rate from$250 million 4.0% to3.0% .
Business Outlook
Based on information as of today,
|
Fourth Quarter Fiscal 2021 |
Full Year Fiscal 2021 |
|
Revenue |
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
|
Year-over-year revenue growth for the fourth quarter of 2021 is forecasted to be
Conference Call Information
CCC will host a conference call today,
About
Forward Looking Statements
This press release contains forward-looking statements that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding future events, goals, plans and projections regarding the company’s financial position, results of operations, market position, product development and business strategy. Such differences may be material. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward looking statements are subject to a number of risks and uncertainties, including, among others, the general economic, political, business and competitive conditions; the impact of COVID-19 on CCC’s business; failure to realize the anticipated benefits of the business combination of CCC’s parent corporation and
Non-GAAP Financial Measures
This press release includes certain financial measures not presented in accordance with generally accepted accounting principles in the
The Company believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Company’s financial condition and results of operations. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends in and in comparing the Company’s financial measures with other similar companies, many of which present similar non-GAAP financial measures to investors. These non-GAAP financial measures are subject to inherent limitations as they reflect the exercise of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures. Please refer to the reconciliations of these measures below to what the Company believes are the most directly comparable measures evaluated in accordance with GAAP.
This press release also includes certain projections of non-GAAP financial measures. Due to the high variability and difficulty in making accurate forecasts and projections of some of the information excluded from these projected measures, together with some of the excluded information not being ascertainable or accessible, the Company is unable to quantify certain amounts that would be required to be included in the most directly comparable GAAP financial measures without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included and no reconciliation of the forward-looking non-GAAP financial measures is included for these projections.
|
||||||||
2021 |
2020 |
|||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
CURRENT ASSETS: | ||||||||
Cash and cash equivalents | $ |
160,465 |
|
$ |
162,118 |
|
||
Accounts receivable—Net of allowances of |
|
82,367 |
|
|
74,107 |
|
||
Income taxes receivable |
|
6,915 |
|
|
2,037 |
|
||
Deferred contract costs |
|
13,833 |
|
|
11,917 |
|
||
Other current assets |
|
36,261 |
|
|
31,586 |
|
||
Total current assets |
|
299,841 |
|
|
281,765 |
|
||
SOFTWARE, EQUIPMENT, AND PROPERTY—Net |
|
121,018 |
|
|
101,438 |
|
||
OPERATING LEASE ASSETS |
|
38,774 |
|
|
- |
|
||
INTANGIBLE ASSETS—Net |
|
1,237,950 |
|
|
1,311,917 |
|
||
|
1,466,884 |
|
|
1,466,884 |
|
|||
DEFERRED FINANCING FEES, REVOLVER—Net |
|
3,053 |
|
|
746 |
|
||
DEFERRED CONTRACT COSTS |
|
18,893 |
|
|
14,389 |
|
||
EQUITY METHOD INVESTMENT |
|
10,228 |
|
|
- |
|
||
OTHER ASSETS |
|
21,584 |
|
|
18,416 |
|
||
TOTAL | $ |
3,218,225 |
|
$ |
3,195,555 |
|
||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||
CURRENT LIABILITIES: | ||||||||
Accounts payable | $ |
16,083 |
|
$ |
13,164 |
|
||
Accrued expenses |
|
81,771 |
|
|
52,987 |
|
||
Income taxes payable |
|
7,161 |
|
|
5,129 |
|
||
Current portion of long-term debt |
|
8,000 |
|
|
25,381 |
|
||
Current portion of long-term licensing agreement—Net |
|
2,661 |
|
|
2,540 |
|
||
Operating lease liabilities |
|
8,855 |
|
|
- |
|
||
Deferred revenues |
|
29,384 |
|
|
26,514 |
|
||
Total current liabilities |
|
153,915 |
|
|
125,715 |
|
||
LONG-TERM DEBT: | ||||||||
First Lien Term Loan—Net |
|
- |
|
|
1,292,597 |
|
||
Term B Loan—Net |
|
780,218 |
|
|
- |
|
||
Total long-term debt |
|
780,218 |
|
|
1,292,597 |
|
||
DEFERRED INCOME TAXES—Net |
|
255,849 |
|
|
322,348 |
|
||
LONG-TERM LICENSING AGREEMENT—Net |
|
34,320 |
|
|
36,331 |
|
||
OPERATING LEASE LIABILITIES |
|
50,550 |
|
|
- |
|
||
WARRANT LIABILITIES |
|
85,348 |
|
|
- |
|
||
OTHER LIABILITIES |
|
6,808 |
|
|
32,770 |
|
||
Total liabilities |
|
1,367,008 |
|
|
1,809,761 |
|
||
COMMITMENTS AND CONTINGENCIES (Notes 22 and 23) | ||||||||
MEZZANINE EQUITY: | ||||||||
Redeemable non-controlling interest |
|
14,179 |
|
|
14,179 |
|
||
STOCKHOLDERS’ EQUITY: | ||||||||
Preferred stock, |
|
- |
|
|
- |
|
||
Common stock— |
||||||||
and outstanding at |
|
60 |
|
|
50 |
|
||
Additional paid-in capital |
|
2,525,750 |
|
|
1,501,206 |
|
||
Accumulated deficit |
|
(688,483 |
) |
|
(129,370 |
) |
||
Accumulated other comprehensive loss |
|
(289 |
) |
|
(271 |
) |
||
Total stockholders’ equity |
|
1,837,038 |
|
|
1,371,615 |
|
||
TOTAL | $ |
3,218,225 |
|
$ |
3,195,555 |
|
||
|
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME
|
|||||||||||||||
For the Three Months Ended | For the Nine Months Ended | ||||||||||||||
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
REVENUES | $ |
176,628 |
|
$ |
157,754 |
|
$ |
501,205 |
|
$ |
467,677 |
|
|||
COST OF REVENUES | |||||||||||||||
Cost of revenues, exclusive of amortization of acquired technologies |
|
51,273 |
|
|
43,879 |
|
|
128,218 |
|
|
135,674 |
|
|||
Amortization of acquired technologies |
|
6,580 |
|
|
6,576 |
|
|
19,740 |
|
|
19,725 |
|
|||
Total cost of revenues |
|
57,853 |
|
|
50,455 |
|
|
147,958 |
|
|
155,399 |
|
|||
GROSS PROFIT |
|
118,775 |
|
|
107,299 |
|
|
353,247 |
|
|
312,278 |
|
|||
OPERATING EXPENSES: | |||||||||||||||
Research and development |
|
67,016 |
|
|
26,816 |
|
|
128,894 |
|
|
82,131 |
|
|||
Selling and marketing |
|
80,382 |
|
|
17,427 |
|
|
121,350 |
|
|
56,608 |
|
|||
General and administrative |
|
142,511 |
|
|
21,893 |
|
|
208,745 |
|
|
66,460 |
|
|||
Amortization of intangible assets |
|
18,078 |
|
|
18,078 |
|
|
54,232 |
|
|
54,232 |
|
|||
Total operating expenses |
|
307,987 |
|
|
84,214 |
|
|
513,221 |
|
|
259,431 |
|
|||
OPERATING (LOSS) INCOME |
|
(189,212 |
) |
|
23,085 |
|
|
(159,974 |
) |
|
52,847 |
|
|||
INTEREST EXPENSE |
|
(13,878 |
) |
|
(19,788 |
) |
|
(51,548 |
) |
|
(57,588 |
) |
|||
GAIN (LOSS) ON CHANGE IN FAIR VALUE OF INTEREST RATE SWAPS |
|
2,007 |
|
|
3,894 |
|
|
8,373 |
|
|
(16,633 |
) |
|||
CHANGE IN FAIR VALUE OF WARRANT LIABILITIES |
|
(26,889 |
) |
|
- |
|
|
(26,889 |
) |
|
- |
|
|||
LOSS ON EARLY EXINGUISHMENT OF DEBT |
|
(15,240 |
) |
|
- |
|
|
(15,240 |
) |
|
(8,615 |
) |
|||
OTHER (EXPENSE) INCOME—Net |
|
(93 |
) |
|
49 |
|
|
1 |
|
|
304 |
|
|||
PRETAX (LOSS) INCOME |
|
(243,305 |
) |
|
7,240 |
|
|
(245,277 |
) |
|
(29,685 |
) |
|||
INCOME TAX BENEFIT (PROVISION) |
|
53,523 |
|
|
(2,520 |
) |
|
54,227 |
|
|
7,191 |
|
|||
NET (LOSS) INCOME INCLUDING NON-CONTROLLING INTEREST |
|
(189,782 |
) |
|
4,720 |
|
|
(191,050 |
) |
|
(22,494 |
) |
|||
Less: net (loss) income attributable to non-controlling interest |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|||
NET (LOSS) INCOME ATTRIBUTABLE TO CCC INTELLIGENT SOLUTIONS | |||||||||||||||
HOLDINGS INC. | $ |
(189,782 |
) |
$ |
4,720 |
|
$ |
(191,050 |
) |
$ |
(22,494 |
) |
|||
Net (loss) income per share attributable to common stockholders: | |||||||||||||||
Basic | $ |
(0.34 |
) |
$ |
0.01 |
|
$ |
(0.36 |
) |
$ |
(0.04 |
) |
|||
Diluted | $ |
(0.34 |
) |
$ |
0.01 |
|
$ |
(0.36 |
) |
$ |
(0.04 |
) |
|||
Weighted-average shares used in computing net (loss) income per | |||||||||||||||
share attributable to common stockholders: | |||||||||||||||
Basic |
|
566,454,782 |
|
|
504,212,021 |
|
|
525,877,533 |
|
|
504,062,587 |
|
|||
Diluted |
|
566,454,782 |
|
|
510,694,493 |
|
|
525,877,533 |
|
|
504,062,587 |
|
|||
COMPREHENSIVE (LOSS) INCOME: | |||||||||||||||
Net (loss) income including non-controlling interest |
|
(189,782 |
) |
|
4,720 |
|
|
(191,050 |
) |
|
(22,494 |
) |
|||
Other comprehensive income (loss)—Foreign currency translation adjustment |
|
11 |
|
|
83 |
|
|
(18 |
) |
|
65 |
|
|||
COMPREHENSIVE (LOSS) INCOME INCLUDING NON-CONTROLLING INTEREST |
|
(189,771 |
) |
|
4,803 |
|
|
(191,068 |
) |
|
(22,429 |
) |
|||
Less: comprehensive (loss) income attributable to non-controlling interest |
|
- |
|
|
- |
|
|
- |
|
|
- |
|
|||
COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO CCC INTELLIGENT | |||||||||||||||
SOLUTIONS HOLDINGS INC. | $ |
(189,771 |
) |
$ |
4,803 |
|
$ |
(191,068 |
) |
$ |
(22,429 |
) |
|||
|
|||||||||
For the Nine Months Ended | |||||||||
|
2021 |
|
|
2020 |
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
Net loss | $ |
(191,050 |
) |
$ |
(22,494 |
) |
|||
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||
Depreciation and amortization of software, equipment, and property |
|
18,161 |
|
|
13,039 |
|
|||
Amortization of intangible assets |
|
73,972 |
|
|
73,957 |
|
|||
Deferred income taxes |
|
(66,499 |
) |
|
(18,018 |
) |
|||
Stock-based compensation |
|
235,413 |
|
|
7,471 |
|
|||
Amortization of deferred financing fees |
|
3,204 |
|
|
3,475 |
|
|||
Amortization of discount on debt |
|
537 |
|
|
553 |
|
|||
Change in fair value of interest rate swaps |
|
(8,373 |
) |
|
16,633 |
|
|||
Change in fair value of warrant liabilities |
|
26,889 |
|
|
- |
|
|||
Loss on early extinguishment of debt |
|
15,240 |
|
|
8,615 |
|
|||
Non-cash lease expense |
|
5,029 |
|
|
- |
|
|||
Other |
|
54 |
|
|
42 |
|
|||
Changes in: | |||||||||
Accounts receivable—Net |
|
(8,332 |
) |
|
(12,644 |
) |
|||
Deferred contract costs |
|
(1,916 |
) |
|
(507 |
) |
|||
Other current assets |
|
(4,673 |
) |
|
(755 |
) |
|||
Deferred contract costs—Non-current |
|
(4,504 |
) |
|
(1,246 |
) |
|||
Other assets |
|
(3,221 |
) |
|
(10,795 |
) |
|||
Operating lease assets |
|
5,133 |
|
|
- |
|
|||
Income taxes |
|
(2,846 |
) |
|
11,597 |
|
|||
Accounts payable |
|
1,399 |
|
|
2,080 |
|
|||
Accrued expenses |
|
17,051 |
|
|
(5,183 |
) |
|||
Operating lease liabilities |
|
(5,935 |
) |
|
- |
|
|||
Deferred revenues |
|
2,861 |
|
|
580 |
|
|||
Extinguishment of interest rate swap liability |
|
(9,987 |
) |
|
- |
|
|||
Other liabilities |
|
(882 |
) |
|
389 |
|
|||
Net cash provided by operating activities |
|
96,725 |
|
|
66,789 |
|
|||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Purchases of software, equipment, and property |
|
(25,022 |
) |
|
(23,815 |
) |
|||
Purchase of equity method investment |
|
(10,228 |
) |
|
- |
|
|||
Purchase of intangible asset |
|
(49 |
) |
|
(560 |
) |
|||
Net cash used in investing activities |
|
(35,299 |
) |
|
(24,375 |
) |
|||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
Proceeds from issuance of non-controlling interest in subsidiary |
|
- |
|
|
14,179 |
|
|||
Deemed distribution to CCCIS option holders |
|
(9,006 |
) |
|
- |
|
|||
Net proceeds from equity infusion from the Business Combination |
|
763,300 |
|
|
- |
|
|||
Principal payments on long-term debt |
|
(1,336,154 |
) |
|
(385,385 |
) |
|||
Proceeds from issuance of long-term debt, net of fees paid to lender |
|
789,927 |
|
|
369,792 |
|
|||
Proceeds from borrowings on revolving lines of credit |
|
- |
|
|
65,000 |
|
|||
Repayment of borrowings on revolving lines of credit |
|
- |
|
|
(65,000 |
) |
|||
Proceeds from issuance of common stock |
|
1,007 |
|
|
- |
|
|||
Payment of fees associated with early extinguishment of long-term debt |
|
(3,320 |
) |
|
(29 |
) |
|||
Proceeds from exercise of stock options |
|
503 |
|
|
618 |
|
|||
Repurchases of common stock |
|
- |
|
|
(123 |
) |
|||
Dividends to CCCIS stockholders |
|
(269,174 |
) |
|
- |
|
|||
Net cash used in financing activities |
|
(62,917 |
) |
|
(948 |
) |
|||
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS |
|
(162 |
) |
|
108 |
|
|||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
|
(1,653 |
) |
|
41,574 |
|
|||
CASH AND CASH EQUIVALENTS: | |||||||||
Beginning of period |
|
162,118 |
|
|
93,201 |
|
|||
End of period | $ |
160,465 |
|
$ |
134,775 |
|
|||
NONCASH INVESTING AND FINANCING ACTIVITIES: | |||||||||
Unpaid liability related to software, equipment, and property | $ |
4,054 |
|
$ |
- |
|
|||
Leasehold improvements acquired by tenant improvement allowance | $ |
10,556 |
|
$ |
- |
|
|||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | |||||||||
Cash paid for interest, excluding extinguishment of interest rate swap liability | $ |
47,312 |
|
$ |
52,217 |
|
|||
Cash received (paid) for income taxes—Net | $ |
(15,119 |
) |
$ |
770 |
|
|||
|
||||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||||
(amounts in thousands, except percentages) |
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
Gross Profit | $ |
118,775 |
|
$ |
107,299 |
|
$ |
353,247 |
|
$ |
312,278 |
|
||||
First Party Clinical Services—Gross Profit |
|
- |
|
|
(645 |
) |
|
- |
|
|
(3,035 |
) |
||||
Amortization of acquired technologies |
|
6,580 |
|
|
6,576 |
|
|
19,740 |
|
|
19,725 |
|
||||
Business combination transaction costs |
|
905 |
|
|
- |
|
|
905 |
|
|
- |
|
||||
Stock-based compensation |
|
12,169 |
|
|
141 |
|
|
12,563 |
|
|
380 |
|
||||
Adjusted Gross Profit | $ |
138,429 |
|
$ |
113,371 |
|
$ |
386,455 |
|
$ |
329,348 |
|
||||
Gross Profit Margin |
|
67 |
% |
|
68 |
% |
|
70 |
% |
|
67 |
% |
||||
Adjusted Gross Profit Margin |
|
78 |
% |
|
76 |
% |
|
77 |
% |
|
75 |
% |
||||
|
||||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||||
(dollar amounts in thousands) |
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
Net operating (loss) income | $ |
(189,212 |
) |
$ |
23,085 |
|
$ |
(159,974 |
) |
$ |
52,847 |
|
||||
Stock-based compensation expense |
|
219,876 |
|
|
1,869 |
|
|
235,413 |
|
|
7,471 |
|
||||
Lease abandonment |
|
438 |
|
|
- |
|
|
2,256 |
|
|
- |
|
||||
Lease overlap costs |
|
924 |
|
|
- |
|
|
2,773 |
|
|
- |
|
||||
Net costs related to divestiture |
|
338 |
|
|
- |
|
|
2,605 |
|
|
- |
|
||||
Business combination transaction costs |
|
5,516 |
|
|
93 |
|
|
10,471 |
|
|
93 |
|
||||
Amortization of intangible assets |
|
18,078 |
|
|
18,078 |
|
|
54,232 |
|
|
54,232 |
|
||||
Amortization of acquired technologies—Cost of revenue |
|
6,580 |
|
|
6,576 |
|
|
19,740 |
|
|
19,725 |
|
||||
First Party Clinical Services—Revenue |
|
- |
|
|
(7,830 |
) |
|
- |
|
|
(26,083 |
) |
||||
First Party Clinical Services—Cost of revenue |
|
- |
|
|
7,185 |
|
|
- |
|
|
23,048 |
|
||||
Adjusted operating income | $ |
62,538 |
|
$ |
49,056 |
|
$ |
167,516 |
|
$ |
131,333 |
|
||||
|
||||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||||
(dollar amounts in thousands) |
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
Net (loss) income | $ |
(189,782 |
) |
$ |
4,720 |
|
$ |
(191,050 |
) |
$ |
(22,494 |
) |
||||
Interest expense |
|
13,878 |
|
|
19,788 |
|
|
51,548 |
|
|
57,588 |
|
||||
Income tax provision (benefit) |
|
(53,523 |
) |
|
2,520 |
|
|
(54,227 |
) |
|
(7,191 |
) |
||||
Amortization of intangible assets |
|
18,078 |
|
|
18,078 |
|
|
54,232 |
|
|
54,232 |
|
||||
Amortization of acquired technologies—Cost of revenue |
|
6,580 |
|
|
6,576 |
|
|
19,740 |
|
|
19,725 |
|
||||
Depreciation and amortization related to software, equipment and property |
|
7,694 |
|
|
4,496 |
|
|
18,161 |
|
|
13,039 |
|
||||
EBITDA |
|
(197,075 |
) |
|
56,178 |
|
|
(101,596 |
) |
|
114,899 |
|
||||
(Gain) loss on change in fair value of interest rate swaps |
|
(2,007 |
) |
|
(3,894 |
) |
|
(8,373 |
) |
|
16,633 |
|
||||
Change in fair value of warrant liabilities |
|
26,889 |
|
|
- |
|
|
26,889 |
|
|
- |
|
||||
Stock-based compensation expense |
|
219,876 |
|
|
1,869 |
|
|
235,413 |
|
|
7,471 |
|
||||
Loss on early extinguishment of debt |
|
15,240 |
|
|
- |
|
|
15,240 |
|
|
8,615 |
|
||||
Business combination transaction costs |
|
5,516 |
|
|
93 |
|
|
10,471 |
|
|
93 |
|
||||
Lease abandonment |
|
438 |
|
|
- |
|
|
2,256 |
|
|
- |
|
||||
Lease overlap costs |
|
924 |
|
|
- |
|
|
2,773 |
|
|
- |
|
||||
Net costs related to divestiture |
|
338 |
|
|
- |
|
|
2,605 |
|
|
- |
|
||||
First Party Clinical Services—Revenue |
|
- |
|
|
(7,830 |
) |
|
- |
|
|
(26,083 |
) |
||||
First Party Clinical Services—Cost of revenue |
|
- |
|
|
7,185 |
|
|
- |
|
|
23,048 |
|
||||
Adjusted EBITDA | $ |
70,139 |
|
$ |
53,601 |
|
$ |
185,678 |
|
$ |
144,676 |
|
||||
|
||||||||||||||||
Three months ended |
Nine months ended |
|||||||||||||||
(dollar amounts in thousands) |
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
|
Net (loss) income | $ |
(189,782 |
) |
$ |
4,720 |
|
$ |
(191,050 |
) |
$ |
(22,494 |
) |
||||
Amortization of intangible assets |
|
18,078 |
|
|
18,078 |
|
|
54,232 |
|
|
54,232 |
|
||||
Amortization of acquired technologies—Cost of revenue |
|
6,580 |
|
|
6,576 |
|
|
19,740 |
|
|
19,725 |
|
||||
(Gain) loss on change in fair value of interest rate swaps |
|
(2,007 |
) |
|
(3,894 |
) |
|
(8,373 |
) |
|
16,633 |
|
||||
Change in fair value of warrant liabilities |
|
26,889 |
|
|
- |
|
|
26,889 |
|
|
- |
|
||||
Stock-based compensation expense |
|
219,876 |
|
|
1,869 |
|
|
235,413 |
|
|
7,471 |
|
||||
Loss on early extinguishment of debt |
|
15,240 |
|
|
- |
|
|
15,240 |
|
|
8,615 |
|
||||
Business combination transaction costs |
|
5,516 |
|
|
93 |
|
|
10,471 |
|
|
93 |
|
||||
Lease abandonment |
|
438 |
|
|
- |
|
|
2,256 |
|
|
- |
|
||||
Lease overlap costs |
|
924 |
|
|
- |
|
|
2,773 |
|
|
- |
|
||||
Net costs related to divestiture |
|
338 |
|
|
- |
|
|
2,605 |
|
|
- |
|
||||
First Party Clinical Services—Revenue |
|
- |
|
|
(7,830 |
) |
|
- |
|
|
(26,083 |
) |
||||
First Party Clinical Services—Cost of revenue |
|
- |
|
|
7,185 |
|
|
- |
|
|
23,048 |
|
||||
Tax effect of adjustments |
|
(72,360 |
) |
|
(5,716 |
) |
|
(89,134 |
) |
|
(26,947 |
) |
||||
Adjusted net income | $ |
29,730 |
|
$ |
21,081 |
|
$ |
81,062 |
|
$ |
54,293 |
|
||||
Adjusted net income per share attributable to common stockholders | ||||||||||||||||
Basic | $ |
0.05 |
|
$ |
0.04 |
|
$ |
0.15 |
|
$ |
0.11 |
|
||||
Diluted | $ |
0.05 |
|
$ |
0.04 |
|
$ |
0.15 |
|
$ |
0.11 |
|
||||
Weighted average shares outstanding | ||||||||||||||||
Basic |
|
566,454,782 |
|
|
504,212,021 |
|
|
525,877,533 |
|
|
504,062,587 |
|
||||
Diluted |
|
599,675,416 |
|
|
510,694,493 |
|
|
554,818,300 |
|
|
510,252,470 |
|
||||
|
|||||||||||||||
Three months ended |
Nine months ended |
||||||||||||||
(dollar amounts in thousands) |
|
2021 |
|
|
|
2020 |
|
|
|
2021 |
|
|
|
2020 |
|
Net cash provided by operating activities | $ |
36,905 |
|
$ |
43,013 |
|
$ |
96,725 |
|
$ |
66,789 |
|
|||
Less: Purchases of software, equipment, and property |
|
(11,864 |
) |
|
(11,303 |
) |
|
(25,022 |
) |
|
(23,815 |
) |
|||
Less: Purchase of intangible assets |
|
- |
|
|
- |
|
|
(49 |
) |
|
(560 |
) |
|||
Free Cash Flow | $ |
25,041 |
|
$ |
31,710 |
|
$ |
71,654 |
|
$ |
42,414 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110006211/en/
Investor Contact:
646-277-1251
IR@cccis.com
Media Contact:
Director Public Relations,
mhellyar@cccis.com
Source:
FAQ
What were CCCS's revenue figures for Q3 2021?
How did CCCS perform in terms of adjusted EBITDA in Q3 2021?
What is the revenue guidance for CCCS in Q4 2021?